Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Raymed Labs

531207
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Raymed Labs Share price and Fundamental Analysis

View All Details
View All Details
Raymed Labs Ltd was established in the year 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymeds quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.
Company Incorporation1992
ChairmanNA
Head QuartersSaharanpur
Previous NameRaymed Labs Ltd

Key Metrics

Market Cap (Cr)
1.56
PE Ratio
0
Industry P/E
36.36
PEG Ratio
0
ROE
6.97%
ROCE
30.27%
ROA
-966.67%
Total Debt (Cr)
2.37
Debt to Equity
-0.92
Dividend Yield
0%
EPS
0
Book Value & P/B
-6.07 x 0
Face Value
10
Outstanding Shares(Cr)
0.43
Current Ratio
0.13
EV to Sales
0

Stock Returns

1 Week%
1 Month+4.89%
6 Months+20.86%
1 Year+39.31%
3 Years+133.97%
5 Years+280.21%
no_data

No Stocks

Smart Score

2.3
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 32.27%

FIIs : 0.00%

DIIs : 0.96%

Public : 66.77%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
Promoter Shareholding Increased by 3.91% to 32.27% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Raymed Labs Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Raymed Labs Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Raymed Labs Ltd was established in the year 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymeds quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.

Raymed strives on a well organized management team of skilled and highly trained professionals from different streams. This team contains chemists, pharmacists, marketing professionals with in-depth knowledge & requirements for human and animal products.

Raymed Labs Share Price

Raymed Labs share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Raymed Labs Market Cap

Market capitalization of Raymed Labs indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Raymed Labs is valued compared to its competitors.

Raymed Labs PE Ratio

Raymed Labs PE ratio helps investors understand what is the market value of each stock compared to Raymed Labs 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Raymed Labs PEG Ratio

The PEG ratio of Raymed Labs evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Raymed Labs ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Raymed Labs generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Raymed Labs ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Raymed Labs in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Raymed Labs Total Debt

Total debt of Raymed Labs shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Raymed Labs Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Raymed Labs compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Raymed Labs CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Raymed Labs over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Raymed Labs Technical Analysis

Technical analysis of Raymed Labs helps investors get an insight into when they can enter or exit the stock. Key components of Raymed Labs Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Raymed Labs shares often struggle to rise above due to selling pressure.

Raymed Labs Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Raymed Labs ’s financial health and profitability.

Raymed Labs Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Raymed Labs Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Raymed Labs Financials

The financials of Raymed Labs provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Raymed Labs Profit and Loss Statements

The profit and loss statement of Raymed Labs highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Raymed Labs .

Raymed Labs Balance Sheet

The balance sheet presents a snapshot of Raymed Labs ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Raymed Labs Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.